Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363610
Status:
TERMINATED
Last Update Posted:
2008-05-20
First Post:
2006-08-09
Brief Title:
A Study Evaluating IV Oncaspar and IV Gemzar in the Treatment of Solid Tumors and Lymphoma
Sponsor:
Enzon Pharmaceuticals Inc
Organization:
Enzon Pharmaceuticals Inc
Organization Data
Organization:
Enzon Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
EZ-002-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Enzon Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Enzon Pharmaceuticals Inc
Old Organization:
None